3'-Cholesterol-TEG CNA CPG
CPG for the incorporation of cholesterol at the 3' end of an oligonucleotide, with a triethylene glycol spacer.
Looking for oligos? Visit our new oligo and Stellaris dedicated platform at
oligos.biosearchtech.com
3'-Cholesterol-TEG CNA CPG Low Bulk Density
CPG for the incorporation of cholesterol at the 3' end of an oligonucleotide, with a triethylene glycol spacer.
5’-Palmitamido-C6 CE-Phosphoramidite
Phosphoramidite used to incorporate a lipophilic palmitoyl-modifier at the 5' end of an oligonucleotide.
3'-Cholesterol CPG
CPG for incorporation of cholesterol at 3' end of an oligonucleotide, with a dR spacer
5'-Cholesterol CE-Phosphoramidite
Phosphoramidite for incorporation of cholesterol at 5' end of an oligonucleotide, with an all-carbon spacer.
3’-Palmitamido-C6-dR CPG
CPG used to incorporate a lipophilic palmitoyl-modifier at the 3' end of an oligonucleotide.
5'-Cholesterol-TEG CE-Phosphoramidite
Phosphoramidite for incorporation of cholesterol at 5' end of an oligonucleotide, with a triethylene glycol spacer.
3'-Cholesterol CPG Column
CPG column for incorporation of cholesterol at 3' end of an oligonucleotide, with a dR spacer.
3’-Palmitamido-C6-dR CPG Column
CPG column used to incorporate a lipophilic palmitoyl-modifier at the 3' end of an oligonucleotide.
3'-Cholesteryl-TEG CPG
CPG for incorporation of cholesterol at 3' end of an oligonucleotide, with a triethylene glycol spacer.
Cholesteryl-TEG CE-Phosphoramidite
CAS No.:873435-29-1
Phosphoramidite for incorporation of cholesterol internally or at 5' end of an oligonucleotide, with a triethylene glycol spacer.
2'-O-C16 A (Bz) CE-Phosphoramidite
Phosphoramidite for the incorporation of a 2’-O-hexadecyl lipophilic chain-modified adenosine internally or at the 5' end of an oligonucleotide.
3'-Dodecanamido-C7 CPG
CPG used to add a lipophilic dodecanoic saturated fatty acid chain to the 3' end of an oligonucleotide.
Dodecanamido-C7 CE-Phosphoramidite
Phosphoramidite for the incorporation of a lipophilic dodecanoic chain internally or at the 5' end of an oligonucleotide, with a C7 spacer.
Palmitamido-C7 CE-Phosphoramidite
Phosphoramidite for the incorporation of a lipophilic palmitoyl-modifier internally or at the 5' end of an oligonucleotide, with a C7 spacer.
3'-Palmitamido-C7 CPG
CPG used to add a lipophilic palmitoyl-modifier to the 3' end of an oligonucleotide, with a C7 spacer.
2'-O-C16 U CPG
CPG used to add a lipophilic 2’-O-hexadecyl lipophilic modified uracil to the 3' end of an oligonucleotide.
2'-O-C16 A (Bz) CPG
CPG used to add a lipophilic 2’-O-hexadecyl lipophilic modified adenosine to the 3' end of an oligonucleotide.
2'-O-C16 C (Bz) CPG
CPG used to add a lipophilic 2’-O-hexadecyl lipophilic modified cytidine to the 3' end of an oligonucleotide.
2'-O-C16 U CE-Phosphoramidite
Phosphoramidite for the incorporation of a 2’-O-hexadecyl lipophilic chain-modified uracil internally or at the 5' end of an oligonucleotide.
Added to basket